Barclays Reports 18 Profit Rise Lifts Income Guidance Google Employee Charged with Insider Trading for 12 Million in Bets Using Internal Data Gold Consolidation Signals Healthy Correction as Fiat Currency Concerns Persist DBS CEO Tan Su Shan Secures Sixth Place on Fortunes 2026 Most Powerful Women List Walmart Inc WMT Analyst Report Retail Giants Resilience Amid Shifting Consumer Trends US Productivity Growth Slows in Q4 as Unit Labor Costs Rise Implications for Inflation and Fed Policy MKTW Q1 2026 Earnings Massive EPS Miss Signals Challenges Ahead ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy LBRDK Q3 2025 Earnings Strong EPS Beat Fueled by Investment Gains Stock Edges Lower Jerash Holdings JRSH Q1 2026 Earnings EPS Surges Past Estimates with 488 Surprise Corteva Inc CTVA Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Margins Face Pressure Chicago Rivet Machine Co CVR Edges Higher as Shares Test Key Resistance Level GoodRx Surges 528 Prescription Savings Platform Tests Key Resistance Zone AtlasClear Holdings ATCH Surges 875 as Key Support Holds at 023 First Guaranty Bancshares Preferred FGBIP Edges Lower as Consolidation Continues SAP Stock Gains Momentum as Price Approaches Key Resistance Level Israeli and Palestinian Entrepreneurs Forge CrossBorder Partnerships Amid Ongoing Conflict BMBL Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick as User Trends Remain in Focus First Advantage FA Trading Lower as Stock Tests Key Support Levels FFBC Q1 2026 Earnings Earnings Beat Bolsters Investor Confidence NATH Q4 2024 Earnings EPS of 096 Signals Resilient Profitability CECO Q1 2026 Earnings EPS Surges 1395 Above Estimates Stock Declines WisdomTree Inc WT Q1 2026 Earnings EPS Beats Estimates Amid Narrow Stock Decline INDI Q1 2026 Earnings EPS Slightly Misses Estimates but Stock Surges on Investor Optimism WKC Q1 2026 Earnings Massive EPS Beat Drives Consideration but Shares Edge Lower Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues